BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3032781)

  • 1. Antibody-independent killing of gram-negative bacteria via the classical pathway of complement.
    Loos M; Clas F
    Immunol Lett; 1987 Feb; 14(3):203-8. PubMed ID: 3032781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria.
    Clas F; Euteneuer B; Stemmer F; Loos M
    Behring Inst Mitt; 1989 Jul; (84):236-54. PubMed ID: 2552981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the classical pathway for the bactericidal effect of normal sera against gram-negative bacteria.
    Clas F; Schmidt G; Loos M
    Curr Top Microbiol Immunol; 1985; 121():19-72. PubMed ID: 3936682
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody-independent killing of gram-negative bacteria via the classical pathway.
    Clas F; Loos M
    Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between complement subcomponent C1q and bacterial lipopolysaccharides.
    Zohair A; Chesne S; Wade RH; Colomb MG
    Biochem J; 1989 Feb; 257(3):865-73. PubMed ID: 2649081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota.
    Clas F; Loos M
    Infect Immun; 1981 Mar; 31(3):1138-44. PubMed ID: 6971812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.
    Albertí S; Marqués G; Camprubí S; Merino S; Tomás JM; Vivanco F; Benedí VJ
    Infect Immun; 1993 Mar; 61(3):852-60. PubMed ID: 8432605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.
    Aubert B; Chesne S; Arlaud GJ; Colomb MG
    Biochem J; 1985 Dec; 232(2):513-9. PubMed ID: 3911948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.
    Loos M
    Prog Allergy; 1982; 30():135-92. PubMed ID: 7041131
    [No Abstract]   [Full Text] [Related]  

  • 10. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q.
    Hoekzema R; Martens M; Brouwer MC; Hack CE
    Mol Immunol; 1988 May; 25(5):485-94. PubMed ID: 3261834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of purified lipoteichoic acid with the classical complement pathway.
    Loos M; Clas F; Fischer W
    Infect Immun; 1986 Sep; 53(3):595-9. PubMed ID: 3488963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complement subcomponent C1q in rheumatic diseases].
    Yonemasu K; Sasaki T
    Ryumachi; 1986 Aug; 26(4):299-311. PubMed ID: 3551118
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of C1q with beta 2-microglobulin.
    Björck L; Johnson U; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():19-23. PubMed ID: 6375255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
    Hsiung L; Dodds AW; Mason DW; Reid KB
    FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for dilution-dependent dissociation of C1q in human serum.
    Hosoi S; Borsos T
    Complement Inflamm; 1989; 6(4):259-69. PubMed ID: 2788553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for an additional serum factor essential for the antibody-independent activation of the classical complement sequence by Gram-negative bacteria.
    Clas F; Loos M
    Infect Immun; 1982 Sep; 37(3):935-9. PubMed ID: 6752030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1q binding and C1 activation by various isolated cellular membranes.
    Storrs SB; Kolb WP; Olson MS
    J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.